Cancer Cells Exploit Alternative Pathways to Sustain Their Growth
In the ever-evolving landscape of cancer metabolism, new insights often challenge long-standing paradigms about how malignant cells sustain their aggressive...
Tarlatamab Combined with Anti-PD-L1 Shows Promising Safety and Unprecedented Overall Survival as First-Line Maintenance Therapy Following Chemo-Immunotherapy in ES-SCLC
In a significant advancement within the landscape of lung cancer therapeutics, novel clinical data unveiled at the 2025 International Association...
“‘Rogue’ DNA Circles Uncover Earliest Insights into Deadly Brain Cancer Development”
A pioneering international research effort has uncovered how circular, extrachromosomal DNA rings—termed ecDNA—play a critical role in propelling the growth...
BMS-986504 Shows Lasting Efficacy in MTAP-Deleted NSCLC, Targeting EGFR and ALK-Positive Tumors
In a groundbreaking development in the fight against non-small cell lung cancer (NSCLC), researchers have unveiled promising results from a...
Phase III Trial Shows Hypofractionated Radiotherapy Plus Chemotherapy Matches Survival Rates and Reduces Toxicity Compared to Conventional Treatment in Limited-Stage SCLC
(Barcelona, Spain — September 8, 2025) — A pivotal multi-center, randomized phase III clinical trial has recently demonstrated that a...
UK Study Finds Lung Cancer Screening Benefits Adults Up to Age 80 Who Are Surgical Candidates
(Barcelona, Spain, September 8, 2025, 10:45 a.m. CEST / UTC +2) — Recent findings presented at the prestigious International Association...
Video-Assisted Thoracoscopy Surgery Lowers Mortality by 21% Compared to Lobectomy
Barcelona, Spain – In a landmark meta-analysis presented at the 2025 International Association for the Study of Lung Cancer (IASLC)...
EA5181 Phase 3 Trial Shows No Overall Survival Advantage for Concurrent Plus Consolidative Durvalumab Over Consolidation Alone in Unresectable Stage 3 NSCLC
(Barcelona, Spain – September 8, 2025, 10:45 a.m. CEST / UTC +2) — In a pivotal development presented at the...
NADIM ADJUVANT Trial Highlights Advantages of Chemo-Immunotherapy After Surgery in Stage IB–IIIA NSCLC
Interim findings from the NADIM ADJUVANT Phase III clinical trial conducted by the Spanish Lung Cancer Group (GECP) have unveiled...
Do Early-Stage Cancer Surgery Patients Face Risk of Long-Term Opioid Use?
New insights into the complex dynamics of opioid use following curative-intent cancer surgery reveal a concerning trend in long-term opioid...
-
Mothers who receive childcare support from maternal grandparents show more parental warmth, finds NTU Singapore study
-
University of Seville Breaks 120-Year-Old Mystery, Revises a Key Einstein Concept
-
Bee body mass, pathogens and local climate influence heat tolerance
-
Researchers record first-ever images and data of a shark experiencing a boat strike
-
Groundbreaking Clinical Trial Reveals Lubiprostone Enhances Kidney Function
Embark on a thrilling journey of discovery with Scienmag.com—your ultimate source for cutting-edge breakthroughs. Immerse yourself in a world where curiosity knows no limits and tomorrow’s possibilities become today’s reality!